-
公开(公告)号：KR1020080038870A
公开(公告)日：2008-05-07
申请号：KR1020060106362
申请日：2006-10-31
Applicant: (주)아모레퍼시픽
CPC classification number: A61K31/198 , A61K31/205 , A61K31/35 , A61K2300/00
Abstract: A composition comprising an extract of soybean including isoflavone, carnitine, caffeine and arginine is provided to promote fat decomposition and fat oxidation and recover insulin sensitivity by increasing expression of adiponectin and a Glut4 gene, thereby showing anti-obese and anti-diabetic effect. A composition for improving obesity and diabetes comprises 0.0001-10 wt.% of isoflavone and 0.001-40 wt.% of L-carnitine as effective ingredients. The composition further comprises 0.0001-10 wt.% of caffeine and 0.001-40 wt.% of arginine. The composition is a health functional food or a medicine and is formulated into tablet, capsule, soft capsule, pill, granule, drink, diet bar, chocolate, caramel or confectionary.
Abstract translation: 提供包含异黄酮，肉碱，咖啡因和精氨酸的大豆提取物的组合物，以通过增加脂联素和Glut4基因的表达来促进脂肪分解和脂肪氧化并恢复胰岛素敏感性，从而显示出抗肥胖和抗糖尿病作用。 用于改善肥胖症和糖尿病的组合物包含0.0001-10重量％的异黄酮和0.001-40重量％的左旋肉碱作为有效成分。 组合物还包含0.0001-10重量％的咖啡因和0.001-40重量％的精氨酸。 该组合物是健康功能食品或药物，并配制成片剂，胶囊，软胶囊，丸剂，颗粒剂，饮料，饮食酒吧，巧克力，焦糖或糖果。
-
公开(公告)号：KR1020060045558A
公开(公告)日：2006-05-17
申请号：KR1020050028894
申请日：2005-04-07
Applicant: (주)아모레퍼시픽
IPC: A61K31/352
Abstract: 본 발명은 대두(soybean)의 주요 이소플라보노이드(isoflavonoid) 중의 하나인 제니스테인(genistein)[5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one]의 신규한 용도에 관한 것으로서, 상기 제니스테인은 지방산 합성 효소(Fatty 유전자의 발현을 억제하고, 이를 통해 지방산 합성효소의 단백질 발현을 억제하며, 더 나아가 지방산 합성 효소(Fatty acid synthase; FAS)의 활성을 억제할 수 있으므로, 제니스테인은 지방산 합성 효소 억제용 조성물로서 사용될 수 있다. 또한, 지방산 합성 효소를 억제하는데 매우 뛰어난 효과를 나타내므로, 비만의 방지 및 치료에 유용하게 이용될 수 있다.
대두, 이소플라노이드, 제니스테인, 지방산 합성 효소, 지방산 합성, 억제, 비만, 방지, 치료, 조성물.-
公开(公告)号：KR1020060028561A
公开(公告)日：2006-03-30
申请号：KR1020040077561
申请日：2004-09-25
Applicant: (주)아모레퍼시픽
IPC: A61K31/35 , A61K31/205
Abstract: 본 발명은 카르니틴 팔미토일트랜스퍼라아제-1(Carnitine PalmitoylTransferase-1: CPT-1) 유전자의 발현을 증가시키는 효능을 가지는 제니스테인(genestein), 다이드제인(daidzein) 또는 글라이시틴(glycitein)을 유효성분으로 함유하는 지방간 개선용 조성물에 관한 것이다. 보다 상세하게는 본 발명은 이소플라본(isoflavone)의 일종인 제니스테인, 다이드제인 및 글라이시틴을 함유하여 지방산 분해경로의 핵심 효소인 카르니틴 팔미토일트랜스퍼라아제-1(CPT-1) 유전자의 발현을 증가시키며 이를 통하여 중성지방 감소, 복부지방 감소 및 말초조직의 중성지방 축적을 감소시키고, 아울러 지방산 산화에 있어 미토콘드리아 내로 지방산을 운반하고 지방의 연소를 촉진하는 카르니틴(carnitine)을 더 함유함으로써 지방간을 개선하는 조성물에 관한 것이다.
제니스테인 * 다이드제인 * 글라이시틴 * CPT-1 * L-카르니틴 * 지방간 * 중성지방-
公开(公告)号：KR1020050067837A
公开(公告)日：2005-07-05
申请号：KR1020030098859
申请日：2003-12-29
Applicant: (주)아모레퍼시픽
IPC: A61K31/352
CPC classification number: A61K8/97 , A61K8/416 , A61K8/4946 , A61K8/498 , A61Q19/06
Abstract: 본 발명은 슬리밍용 조성물에 관한 것으로, 보다 상세하게는 데아닌(theanine)과 카페인(caffeine), 제니스테인(genistein) 및 카르니틴(L-carnitine)으로 이루어진 군에서 선택된 1종 이상을 함유하는 슬리밍용 조성물에 관한 것이다. 본 발명의 조성물은 데아닌과 카페인, 제니스테인 및 카르니틴을 단독 또는 혼합물의 형태로 함유하여 우수한 지방 분해효과 및 셀룰라이트의 제거 효과를 나타낸다.
-
公开(公告)号：KR101272976B1
公开(公告)日：2013-06-10
申请号：KR1020060090855
申请日：2006-09-19
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 경구용 피복 조성물에 관한 것으로, 보다 구체적으로는 탄소수 18개의 지방산 80~92 중량% 및 탄소수 16개의 지방산 8~12 중량 % 함유하는 식물성 유지를 포함하는 경구용 피복 조성물에 관한 것이다.
본 발명에 따른 경구용 피복 조성물을 이용하면 생체 흡수율이 향상될 뿐만 아니라 카테킨의 쓴맛과 위장장애가 저감된 녹차 카테킨을 제공할 수 있고, 또한 난용성 물질인 이소플라본이 지용성으로 물성이 개선되고, 생체내 흡수율을 높인 이소플라본을 제공할 수 있다.
코팅, 녹차, 카테킨, 이소플라본, 식물성 유지, 흡수율-
Patent Agency Ranking
公开(公告)号：KR1020090030441A
公开(公告)日：2009-03-25
申请号：KR1020070095753
申请日：2007-09-20
Applicant: (주)아모레퍼시픽
CPC classification number: A23L33/21 , A23L33/10 , A23L33/30 , A23V2002/00 , A23V2200/332 , A23V2250/5058
Abstract: A food composition containing dietary fiber and fructooligosaccharide for reducing abdominal obesity is provided to give satiety, to promotes the evacuation and to take the food composition without side effects for a long term. A food composition for reducing abdominal obesity contains inulin and fructooligosaccharide. The food composition for reducing abdominal obesity further contains glucomannan and red wine extracts. Particularly, the food composition for reducing abdominal obesity comprises inulin 3-25 g, the fructo-oligosaccharide 0.5-10 g, and the red wine extracts 0.01-2 g and glucomannan 0.1-5 g based on the dry weight.
Abstract translation: 提供含有用于降低腹部肥胖的膳食纤维和低聚果糖的食物组合物以产生饱腹感，以促进排泄并长期服用食物组合物而没有副作用。 用于减少腹部肥胖的食物组合物含有菊粉和低聚果糖。 用于减少腹部肥胖的食物组合物还含有葡甘露聚糖和红葡萄酒提取物。 特别地，用于减少腹部肥胖的食物组合物包括3-25g的菊粉，0.5-10g的低聚果糖，0.01-2g的红葡萄酒提取物和基于干重的0.1-5g的葡甘露聚糖。
-
公开(公告)号：KR1020130053274A
公开(公告)日：2013-05-23
申请号：KR1020110118988
申请日：2011-11-15
Applicant: (주)아모레퍼시픽
IPC: G06Q50/22
CPC classification number: G09B19/0092 , G06F19/00 , G06Q50/22
Abstract: PURPOSE: A system and a method for diet management are provided to classify personal data of users by body type, and offer a customized solution according to diet objective, lifestyle analysis result, and state diagnosis data that are classified by the body type. CONSTITUTION: A diet management server receives person informative data of a user from an information input terminal through a data transmitting/receiving unit(S310). The diet management server generates body type classification data by classifying users by body types with received state diagnosis data, and transmits the generated body type classification data to a data DB though the data transmitting/receiving unit(S320). A lifestyle analysis unit of the diet management server generates result of lifestyle analysis according to received lifestyle data(S330). A solution generation unit of the diet management server generates a solution for each user using a solution data DB based on a diet objective of each user, the analysis result of lifestyle and state diagnosis data(S340). A customization service providing unit of the diet management server provides a customized solution which is changed in accordance with a current situation of the user by receiving the current situation of the user(S350). [Reference numerals] (510) Receive user's BMI and 3D body type analysis result from a state diagnosis DB; (520) Classify body fat degrees according to the user's BMI; (530) Classify body types according to the user's 3D body type analysis result; (540) Determine user's body type based on the body fat degree and body type classifications; (550) Generate body type classification data and store in a body type classification DB; (AA) Start; (BB) End
Abstract translation: 目的：提供一种用于饮食管理的系统和方法，根据身体类型对用户的个人数据进行分类，并根据体格分类的饮食目标，生活方式分析结果和状态诊断数据提供定制解决方案。 规定：饮食管理服务器通过数据发送/接收单元从信息输入终端接收用户的个人信息数据（S310）。 饮食管理服务器通过用接收到的状态诊断数据的身体类型对用户进行分类，生成身体类型分类数据，并且通过数据发送/接收单元将生成的身体类型分类数据发送到数据DB（S320）。 饮食管理服务器的生活方式分析单元根据接收到的生活方式数据生成生活方式分析的结果（S330）。 饮食管理服务器的解决方案生成单元基于每个用户的饮食目标，生活方式和状态诊断数据的分析结果，使用解决方案数据DB为每个用户生成解决方案（S340）。 饮食管理服务器的定制服务提供单元提供通过接收用户的当前状况根据用户的当前情况而改变的定制解决方案（S350）。 （附图标记）（510）从状态诊断DB接收用户的BMI和3D体型分析结果; （520）根据用户的身体质量指数对身体脂肪度进行分类; （530）根据用户的3D体型分析结果对身体类型进行分类; （540）根据身体脂肪度和体型分类确定使用者的身体类型; （550）生成体型分类数据并存储在体型分类DB中; （AA）开始; （BB）结束
-
公开(公告)号：KR1020080049330A
公开(公告)日：2008-06-04
申请号：KR1020060119769
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
CPC classification number: A23L33/19 , A23L29/244 , A23L33/105 , A23L33/185 , A23L33/40
Abstract: A food composition including glucomannan, whey protein and isolated soybean protein as essential nutrients is provided to maximize a feeling of satiety during or after a meal, and thus can be effective to induce weight loss. A food composition contains 0.1 to 33% by weight of whey protein, 0.1 to 30% by weight of isolated soybean protein, 0.01 to 10% by weight of glucomannan and additionally vitamin or inorganic matter and 1 to 50% by weight of Chia seed. The weight ratio of glucomannan, whey protein and isolated soybean protein is 0.25 to 1.25:1.0 to 4.55:1.37 to 7.94. The food composition is formulated into dry powder, granule, capsule, tablet, pill, drink, oil-phase liquid, diet bar, chocolate, caramel, cereal and confectionery and has a caloric content of 50 to 500Kcal.
Abstract translation: 提供包括葡甘露聚糖，乳清蛋白和分离的大豆蛋白作为必需营养素的食物组合物，以在餐中或餐后最大化饱腹感，因此可有效诱导体重减轻。 食品组合物含有0.1〜33重量％的乳清蛋白，0.1〜30重量％的分离的大豆蛋白，0.01〜10重量％的葡甘露聚糖，另外含有维生素或无机物质，1〜50重量％的Chia种子。 葡甘聚糖，乳清蛋白和分离的大豆蛋白的重量比为0.25〜1.25：1.0〜4.55：1.37〜7.94。 食品组合物配制成干粉，颗粒，胶囊，片剂，丸剂，饮料，油相液体，饮食棒，巧克力，焦糖，谷物和糖果，热量含量为50〜500Kcal。
-
公开(公告)号：KR100726281B1
公开(公告)日：2007-06-11
申请号：KR1020060071983
申请日：2006-07-31
IPC: C07C59/147 , C07C59/185 , C07C59/125
Abstract: Provided is a novel fatty acid ester compound, which has an effect of inhibiting protein tyrosine phosphatase 1B, is derived from a naturally occurring plant, and is effective for treating diabetes and obesity. The fatty acid ester compound is selected from the group consisting of the compounds represented by formulae 1-6. The fatty acid ester compound is derived from Siegesbeckia orientalis through extraction, ethanol extraction and chromatography steps.
Abstract translation: 本发明提供具有抑制蛋白质酪氨酸磷酸酶1B的效果的新型脂肪酸酯化合物，其源自天然植物，对治疗糖尿病和肥胖症是有效的。 脂肪酸酯化合物选自由式1-6表示的化合物。 脂肪酸酯化合物通过提取，乙醇提取和色谱步骤从Siegesbeckia orientalis衍生而来。
-
公开(公告)号：KR1020100028616A
公开(公告)日：2010-03-12
申请号：KR1020100015699
申请日：2010-02-22
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: An oral composition for preventing and treating obesity is provided to promote fat lysis and combustion using soybean extract, carnitine, caffeine and arginine. CONSTITUTION: An oral composition for preventing and treating obesity contains 0.0001-10 weight% of isoflavone, 0.001-40 weight% of L-carnitine, 0.0001-10 weight% of caffeine, and 0.001-40 weight% of arginine as an active ingredient. The isoflavone is a soybean extract containing the isoflavone. An inhibitor of abdomenal obesity contains the oral composition.
Abstract translation: 目的：提供一种用于预防和治疗肥胖症的口服组合物，以促进使用大豆提取物，肉碱，咖啡因和精氨酸的脂肪裂解和燃烧。 构成：用于预防和治疗肥胖症的口服组合物含有0.0001-10重量％的异黄酮，0.001-40重量％的L-肉毒碱，0.0001-10重量％的咖啡因和0.001-40重量％的精氨酸作为活性成分。 异黄酮是含有异黄酮的大豆提取物。 腹部肥胖的抑制剂含有口服组合物。
-
-
-
-
-
-
-
-
-
Search Results
18
records
(took 0.038 seconds)
